Category Language

European Parliament Committee Copyright, Trade Secret Votes

In voting that took over an hour due to the more than 550 amendments proposed, the European Parliament Legal Affairs (JURI) Committee Tuesday adopted an own-initiative report by German MEP Julia Reda of the Greens/European Free Alliance intended to make sweeping changes to EU copyright law. The report is expected to feed into the European Commission's (EC's) copyright reform proposal expected later this year. JURI also backed draft rules on legal redress for theft and misuse of business trade secrets, but said they must in turn respect freedom of information and expression and safeguard whistle-blowers.

ICANN Is Not The Internet Content Police

ICANN's Allen Grogan writes: Allow me to say this clearly and succinctly – ICANN is not a global regulator of Internet content, nor should the 2013 Registry Accreditation Agreement (RAA) be interpreted in such a way as to put us in that role. Our mission is to coordinate, at the overall level, the global Internet's systems of unique identifiers, and in particular, to ensure the stable and secure operation of the Internet's unique identifiers. ICANN was never granted, nor was it ever intended that ICANN be granted, the authority to act as a regulator of Internet content.

EPO Director Says Keep Patent Harmonisation Multilateral; Defends Staff Moves

European Patent Office President Benoît Batistelli, in an exchange with the Legal Affairs Committee (Juri) of the European Parliament today (15 June), recommended against including harmonisation of patent policy in bilateral negotiations like the Trans-Atlantic Trade and Investment Partnership (TTIP). He also defended his office's actions on heated staff matters. But he did not address a breaking allegation of EPO surveillance of computers in its building.

Report: European Patent Office Tapped Computers

A story in the German newspaper Süddeutsche Zeitung says, according to an unofficial translation, that it has obtained an internal report that shows the European Patent Office (EPO) tapped two general use computers it had identified as a source for leaked information. The news comes on the eve of a meeting of the EPO president with the European Parliament.

LDC Pharma Extension Request At WTO Yields Support But Needs Further Discussion

World Trade Organization members this week could not decide on a request from least-developed countries to extend a waiver allowing them to forego the enforcement of intellectual property rights on pharmaceutical products until their economies are stronger. Discussions are expected to be conducted informally until the next meeting of the organisation’s council on IP rights in October.

EU Sees Flurry Of IP Policy Activity

With European Commission proposals for copyright reform expected later this year, EU lawmakers, rights-holders and digital rights activists are pushing for major policy shifts. European Parliament resolutions approved on 9 June call for stronger intellectual property protections in non-EU countries, and better internal enforcement against online breaches. A controversial draft report seeking more harmonisation of EU copyright measures has attracted around 600 proposed amendments and will be voted on 16 June. Meanwhile, the Council said it reached agreement with Parliament on changes to EU trademark law.

US Shifts Stance On Drug Pricing In Pacific Trade Pact Talks, Document Reveals

From the New York Times: WASHINGTON — Facing resistance from its Pacific trading partners, the Obama administration is no longer demanding protection for pharmaceutical prices under the 12-nation Trans-Pacific Partnership, according to a newly leaked “transparency” annex of the proposed trade accord.

But American negotiators are still pressing participating governments to open up the process that sets reimbursement rates for drugs and medical devices. Public health professionals, generic drugmakers and activists opposed to the trade deal, which is still being negotiated, contend that it will empower big pharmaceutical firms to command higher reimbursement rates in the United States and abroad, at the expense of consumers.